Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
2.21    0.00 (0.00%)
Bid:
2.00
Ask:
2.19
Spread: 0.19 (9.50%)
Market Cap: £44.34m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Quintain acquires Aldermary House, EC4

1 May 2014 07:00

RNS Number : 0337G
Quintain Estates & Development PLC
01 May 2014
 



 

1 May 2014

 

Quintain Estates & Development PLC

("Quintain" / "Company" / "Group")

 

Quintain acquires Aldermary House, EC4

 

In line with the strategy of broadening its London interests, Quintain has acquired all of the units in the Aldermary House Unit Trust, which owns the leasehold interest in Aldermary House, 10-15 Queen Street EC4, for £40.0 million in cash (before rental top-up adjustments).

 

The ten storey building is centrally located in the City of London opposite Bloomberg Place, the construction site of Bloomberg's new London headquarters, which is scheduled to open in September 2016 and will contain a new entrance to Bank Underground Station.

 

The rental income at Aldermary House, including top-ups, is approximately £2.5 million, representing a yield of 6.1%. The asset contains 61,990 sq ft of commercial space, of which 50,129 sq ft is office and 11,861 sq ft retail. 45,339 sq ft of the office space is let to 13 occupiers with a further 4,790 sq ft of recently refurbished space available to lease. The 11,861 sq ft of retail space is let to five tenants. The average rent, including the available space, is circa £42.00 psf.

 

The building has been partially refurbished in the last two years and the asset offers further opportunity for active management. The weighted average unexpired lease term across the building is 8 years.

 

The units in the Aldermary House Unit Trust are being acquired from AFH Investment LP, which is jointly owned by Columbus UK Real Estate Fund L.P. and the British Airways Pension Fund and managed by Columbus Capital Management LLP.

 

Maxwell James, Chief Executive of Quintain, said: "We are delighted to have made our second acquisition for Quintain's London Portfolio in this excellent City location.

 

"Our ability to actively manage the property, combined with the strength of the existing location and improvements that are underway, will deliver a strong and growing income stream, whilst providing the potential for additional value creation to the Group."

 

Quintain was advised by Michael Elliott. Columbus Capital was advised by Savills and Capital Real Estate Partners.

 

ENDS

 

Enquiries:

 

Quintain Estates and Development PLC

RLM Finsbury

Maxwell James / Richard Stearn

Cressida Curtis

Jenny Davey

Charlotte Whitley

Tel: +44 (0) 20 7495 8968

Tel: +44 (0) 20 7251 3801

 

 

 

 

Forward looking statements

This announcement is for information purposes only and contains certain forward-looking statements which, by their nature, involve risk and uncertainty because they relate to or depend upon future events and circumstances.

 

There are a number of factors which could cause actual results and developments to differ materially from those expressed or implied by these forward looking statements, including a number of factors outside Quintain's control. All forward-looking statements are based upon information known to Quintain on the date of this announcement and no representation or warranty is given in relation to them, including as to their completeness or accuracy or the basis on which they were prepared. Quintain gives no undertaking to update forward-looking statements whether as a result of new information, future events or otherwise. Information contained in this announcement relating to the Company should not be relied upon as an indicator of future performance.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQLIFEEELILIIS
Date   Source Headline
15th Apr 20267:00 amRNSDirectorate change
23rd Mar 20267:00 amRNSInterim Results & Notice of Investor Presentation
19th Mar 20267:00 amRNSAppointment of Non-Executive Director
3rd Feb 20267:00 amRNS-RPublication of 2025 Sustainability Report
12th Jan 20267:00 amRNSExtension of Exclusive Agreement with Nouryon
9th Jan 20267:00 amRNSDirector/PDMR Shareholding and Directorate Change
4th Dec 202512:17 pmRNSDirector/PDMR Shareholding
28th Nov 20252:55 pmRNSResult of AGM
28th Nov 20257:00 amRNSAGM Statement
7th Nov 20253:01 pmRNSDirector/PDMR Shareholding
6th Nov 20251:46 pmRNSDirector/PDMR Shareholding
28th Oct 20255:23 pmRNSPosting of Annual Report and Notice of AGM
27th Oct 20257:00 amRNSIssue of Options and Director Dealing
13th Oct 20257:00 amRNSIssue of Share Options and Director/PDMR Dealing
29th Sep 20257:00 amRNSFinal Results and Notice of AGM
26th Sep 20257:00 amRNSValkor update
17th Sep 20257:00 amRNSSuccessful Sparkle Power Programme Testing
15th Sep 20257:00 amRNSCEO Appointment
18th Aug 20257:00 amRNSBusiness Update
25th Jul 20257:00 amRNSDirector / PDMR Shareholding
14th Jul 20258:00 amRNSDirector/PDMR Shareholding
4th Jul 202511:50 amRNSExercise of Options and Total Voting Rights
17th Jun 20257:00 amRNSJoint Development Agreement with Alder Energy LLC
10th Jun 20257:00 amRNSBusiness Update
23rd May 20257:00 amRNSExercise of Warrants
1st May 20257:01 amRNSTotal Voting Rights
1st May 20257:00 amRNSManagement Update
3rd Apr 20257:00 amRNSExercise of Share Options
1st Apr 20257:00 amRNSMAC2 Services Agreement
26th Mar 202512:46 pmRNSDirector/PDMR Shareholding
26th Mar 20257:00 amRNSLicella Joint Development Agreement
24th Mar 20257:00 amRNSInterim Results and Investor Presentation
13th Mar 20257:00 amRNS-RAppointment of Head of Marine
31st Jan 20257:00 amRNSResult of Retail Offer
30th Jan 20252:36 pmRNSIncrease of Retail Offer
28th Jan 20257:00 amRNSAppointment of Director
24th Jan 202510:04 amRNSRetail Offer - Notice of IMC Presentation
24th Jan 20257:05 amRNSRetail Offer
24th Jan 20257:00 amRNSResult of Placing and Subscription
23rd Jan 20254:51 pmRNSProposed Placing, Subscription and Retail Offer
15th Jan 20257:00 amRNSValkor License Revenues
16th Dec 20247:00 amRNSMaterial Transfer Agreement with Sparkle Power SA
5th Dec 20247:00 amRNS-RbioMSAR™ Development Update
26th Nov 20247:00 amRNSProject Agreement with MSC and Cargill
25th Nov 20247:00 amRNSCollaboration Agreement with Auramarine
22nd Nov 20244:57 pmRNSResult of AGM
22nd Nov 20247:00 amRNSAGM Statement
25th Oct 20244:05 pmRNSPosting of Annual Report & Notice of AGM
30th Sep 20247:00 amRNSFinal Results and Notice of AGM
2nd Aug 20247:00 amRNSIssue of Share Options and Director/PDMR Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.